Table 1.

Frequency and clinical consequences of recurrent gene mutations in patients with MDS

Frequency and clinical consequences of recurrent gene mutations in patients with MDS
View large
Frequency and clinical consequences of recurrent gene mutations in patients with MDS

NA indicates not available.

*MDS/MPN indicates overlap syndromes per the World Health Organization (2008), including CMML-1/CMML-2; sAML, MDS-derived secondary AML. Mutation frequencies are based on studies that genotyped > 30 patients except MDS patients with RUNX1 mutations (n = 23) and all sAML frequencies (n > 20).

†Inconsistent impact on survival reported.

View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal